BridgeBio Oncology Therapeutics Inc.
BBOT | NASDAQ
$4.70
+$0.04 (+0.86%)
Sep 22, 2026, 11:08 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -56.45M | -42.11M | -38.8M | -44.76M | -28.44M | -487.39K | 1.95M | -17.32M | 2.21M | -15.44M | -41.69K |
Depreciation & Amortization | 76K | 186K | 194K | 416K | 181K | n/a | n/a | 156K | n/a | 52K | n/a |
Stock-Based Compensation | 7.23M | n/a | 2.95M | n/a | 875K | 57.92K | 77.4K | n/a | 77.4K | 1.57M | n/a |
Other Working Capital | 14.92M | -8.48M | -4.07M | 10.42M | 6.53M | 20.24K | 22.75K | 11.54M | 123.24K | 5.25M | n/a |
Other Non-Cash Items | -4.8M | 3.8M | -89K | -36.7M | -389K | -325.41K | -2.25M | -33.72M | -2.44M | -1.25M | 41.69K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 9.59M | 2.21M | -6.49M | 10.42M | 4.48M | 20.24K | 127.45K | 11.54M | 123.24K | 4.96M | n/a |
Operating Cash Flow | -44.36M | -35.92M | -42.23M | -70.63M | -23.29M | -734.64K | -87.86K | -39.34M | -29.1K | -8.87M | n/a |
Capital Expenditures | -47K | -24K | -73K | -533K | -231K | n/a | n/a | -39K | n/a | -14K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -7.54M | -311.65M | -21.04M | -62.88M | -33.99M | n/a | n/a | 29.57M | n/a | n/a | n/a |
Sales Maturities Of Investments | 53.31M | 26.26M | 28.88M | 128.98M | 43.86M | n/a | n/a | 5.98M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.41M | n/a | 2.41M | n/a |
Investing Cash Flow | 45.73M | -285.41M | 7.77M | 65.56M | 9.64M | n/a | n/a | 37.91M | n/a | 2.39M | n/a |
Debt Repayment | n/a | n/a | n/a | 373.46M | n/a | n/a | 209.85K | 209.85K | n/a | -209.85K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -121K | -586K | -11.69M | -3.27M | n/a | 187.04M | 1.06M | n/a | 209.85K | n/a |
Financial Cash Flow | 37K | 295K | -586K | 383.99M | 18.96M | n/a | n/a | 19.78M | n/a | 6.65M | n/a |
Net Cash Flow | 1.41M | -321.03M | -35.05M | 408.08M | 5.3M | -734.64K | -87.86K | -28.86K | -29.1K | 174K | n/a |
Free Cash Flow | -44.41M | -35.94M | -42.31M | -71.16M | -23.52M | -734.64K | -87.86K | -39.38M | -29.1K | -8.88M | n/a |
Adj. Free Cash Flow | -51.64M | -35.94M | -45.25M | -71.16M | -24.4M | -792.56K | -165.26K | -39.38M | -106.5K | -10.45M | n/a |
Maintenance CapEx | -47K | -24K | -73K | -416K | -181K | n/a | n/a | -39K | n/a | -14K | n/a |
Growth CapEx | n/a | n/a | n/a | -117K | -50K | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -44.41M | -35.94M | -42.31M | -71.04M | -23.47M | -734.64K | -87.86K | -39.38M | -29.1K | -8.88M | n/a |
Add to Watchlist
Select watchlists to add or remove BBOT